We use a small number of cookies to give you the best experience of our website. If you continue to view the Positive Action site we'll assume that you are happy to receive these cookies. Find out exactly what cookies we use and how to turn them off.


HIV in the News

This page contains the most recent HIV related news from NAM aidsmap. You can read the full story by clicking on the headlines.

"I approached him when he was in his good moods": how pregnant women introduce HIV self-tests to their partners

Providing HIV self-testing kits to pregnant women to encourage HIV testing in their male partners is acceptable to men and women in Uganda, but women who are apprehensive about their partners? reactions may need more support, according to findings from a qualitative study of participants in a randomised trial of the strategy published in ... full story

Fri, 21 Sep 2018

Immunotherapy shows promise as a treatment for HIV-related Kaposi sarcoma

Immunotherapy may be an effective treatment for HIV-related Kaposi sarcoma (KS), according to the results of a small US study published in Cancer Immunology Research. Two-thirds of people experienced partial or complete remission and the malignancy remained stable in the remaining people. Therapy with an immune checkpoint blockade was also associated with increases in CD4 ... full story

Thu, 20 Sep 2018

US doctors? organisation endorses event-based PrEP for the first time

For the first time, a US-based professional HIV body has published guidelines endorsing event-based or so-called ?on-demand? pre-exposure prophylaxis (PrEP) as an alternative to daily dosing. The International Antiviral Society-USA (IAS-USA) released its 2018 recommendations during the International AIDS Conference in Amsterdam, but there was not much comment on their significance at the time. Bodies issuing ... full story

Wed, 19 Sep 2018

Do-it-yourself HIV prevention: who do men buying PrEP online get support from?

Gay men in London who source their own supply of generic pre-exposure prophylaxis (PrEP) drugs, usually from overseas internet pharmacies, most often learnt about this possibility from people in their social network and would like more support from other PrEP users to be available. Nonetheless, clinicians? endorsement of purchasing PrEP online was important in ... full story

Tue, 18 Sep 2018

Findings of large study suggest that HIV should be considered a major risk factor for cardiovascular disease

People living with HIV are twice as likely to develop cardiovascular disease (CVD), according to the findings of a meta-analysis published in Circulation. The research also showed that HIV is the cause of 1% of global CVD cases and that the burden of HIV-associated CVD has tripled over the last 20 years. The majority ... full story

Mon, 17 Sep 2018

TB symptom screen less likely to detect active TB in people taking HIV treatment

The four-symptom screen for active tuberculosis (TB) that is recommended for all people living with HIV in lower-income settings is less likely to detect active TB in people taking antiretroviral therapy (ART) and may be improved by the additional use of a chest x-ray, according to a systematic review and meta-analysis by the World ... full story

Fri, 14 Sep 2018

Stigma remains a substantial barrier in accessing HIV care in rural East Africa

A set of varied barriers adversely impact positive outcomes at different stages in the HIV care cascade in the rural East African context, according to a qualitative study recently published in PLOS ONE by James Ayieko and fellow researchers. This study highlights the important role played by factors ranging from the psychosocial (such as ... full story

Fri, 14 Sep 2018

High rates of smoking in people with HIV in sub-Saharan Africa

Having HIV is associated with a greater likelihood of cigarette smoking and using smokeless tobacco, according to research conducted in 25 sub-Saharan African countries and published in Nicotine and Tobacco Research. After taking into account other factors associated with tobacco use, people living with HIV were approximately 12% more likely to smoke cigarettes and over 34% ... full story

Thu, 13 Sep 2018

Two new doravirine pills approved in US

The US Food and Drug Administration (FDA) has approved two new products containing the next-generation non-nucleoside reverse transcriptase inhibitor (NNRTI) doravirine. These products are also under review by the European Medicines Agency.Produced by Merck/MSD, Pifeltro is a stand-alone doravirine tablet that must be taken with other antiretrovirals. Delstrigo is a fixed-dose pill (single-tablet regimen) containing doravirine plus ... full story

Wed, 12 Sep 2018

Developmental problems of children born to women with HIV linked to substance use and HIV, not antiretrovirals

Pre-term births and developmental problems in children born to mothers with HIV are associated with HIV infection, substance use and smoking, Canadian researchers have reported in the journal AIDS. They could not find a significant relationship with antiretroviral drug exposure. Some studies have reported higher rates of pre-term births in mothers living with HIV, ... full story

Tue, 11 Sep 2018

You can read older stories on the NAM aidsmap news page.